Alfa Chemistry Leads the Way to Unleash Power of Computational Solutions in Solid State Chemistry for Pharmaceutical Research

PrecisionLife Project Awarded Innovate UK Grant to Improve Diagnosis and Treatment of ME/CFS and Long Covid

Leading computational biology company PrecisionLife®, which is driving precision medicine in complex chronic diseases, the ME/CFS charity Action for M.E., and the MRC Human Genetics Unit at the Institute of Genetics and Cancer, University of Edinburgh have been awarded a £622,000 grant by Innovate UK's Advancing Precision Medicine programme to improve diagnosis and treatment for the millions of people affected by ME/CFS and long Covid.

Oz-UK Ltd announces new low-GWP manufacturing line installation to meet global need for pMDIs ahead of the Kigali Amendment deadline

Oz-UK Ltd announces the installation of its new low-GWP (global warming potential) manufacturing line.

New Hyfe AI Study Validates the Accuracy of AI-Powered Cough Detection Human Annotators

Research demonstrates the accuracy of Hyfe’s automated cough monitoring process and is the first to observe differences in type and length of cough between men and women.

Almaden Genomics’ g.nome™ Further Enhances Single-Cell Analysis

Almaden Genomics has incorporated an end-to-end solution into g.nome™ to process, analyze, and visualize single-cell RNAseq data. A cloud-native platform designed for high-throughput sequencing data analysis, g.nome now includes features for alignment and quantification of gene expression per cell, Seurat clustering analysis, reference-based cell-type annotation, and built-in parallelization.

DnaNudge secures FDA approval to deploy a Multiplex PCR platform for diagnosing four-in-one respiratory pathogens in Ghana

Medical and consumer genetics testing innovator and Imperial College London spin-out, DnaNudge, today announces that it has received approval from Ghana’s Food and Drugs Authority (FDA) to deliver its breakthrough four-in-one, respiratory viruses test for clinical deployment both inside and outside labs in the West African country.

ReciBioPharm partners with Acuitas Therapeutics to provide rapid technology transfers and CGMP manufacture of Acuitas’ LNP formulations

I just wanted to follow up to see if you had received my initial email regarding ReciBioPharm partners with Acuitas Therapeutics? Please let me know if there is any further information you require from me for this.

Vergent Bioscience Initiates Phase 2, Multi-Center VISUALIZE Study Evaluating Efficacy of Tumor-targeted Fluorescent Imaging Agent VGT-309 in Lung Cancer Surgeries

Vergent Bioscience has enrolled the first patients in a Phase 2, multi-center study evaluating the efficacy and safety of VGT-309 in patients with cancer in the lung. Researchers at six sites in the U.S. and Australia will investigate the agent’s ability to help surgeons see tumors in real time during minimally invasive and robotic-assisted surgical procedures.

Swedish innovation evaluated for clinical diagnosis of pediatric leukemia

Qlucore, a leader in software development for precision cancer diagnostics, has taken a significant and crucial step towards obtaining a CE marked solution, initiating a formal performance evaluation study in Sweden and Denmark. Results from the study are expected early in 2024.

Frost & Sullivan Names AppOmni Company of the Year for Global SaaS Security Posture Management

Analyst firm, Frost & Sullivan today named AppOmni its Company of the Year for global SaaS Security Posture Management (SSPM) industry leadership. According to the report: “While many market participants are enhancing their SSPM solutions by increasing the number of SaaS applications being covered, the market still has an unmet need for an SSPM solution that provides consistent and comprehensive security coverage across core and custom SaaS applications. AppOmni addresses this market demand by offering its one-stop AppOmni Platform, which is the first SSPM solution in the market that enables customers to implement common security capabilities across their entire SaaS ecosystem.”

Joint report from Ashfield Event Experiences, part of Inizio Engage XD, and IPCAA provides insights to drive future medical congress and convention success

I wanted to share some exciting insights from a joint report by Ashfield Event Experiences, part of Inizio Engage XD, and the International Pharmaceutical Congress Advisory Association (IPCAA). This report delves into the evolving landscape of healthcare provider (HCP) behaviors and attitudes towards medical congresses and conventions, particularly in the context of the return of in-person events. The full release is below.

Life Science Tools Industry | Future Growth Prospects

The industry growth include Increased government funding for life science technologies, growth of cell and gene therapies, rise in demand for biopharmaceuticals, technological advancements in life science tools, rise in the number of strategic deals & developments, and applications of genomic and proteomic technologies for precision medicine.

Tome Biosciences Launches with Over $200 Million in Funding to Advance Programmable Genomic Integration Platform

ome Biosciences, Inc., the programmable genomic integration company, has launched to usher in a new era of genomic medicines based on programmable genomic integration (PGI). PGI enables the insertion of any DNA sequence, of any size, into any programmed genomic location. The Company has raised $213 million in Series A and B funding from investors: Andreessen Horowitz (a16z) Bio + Health, ARCH Venture Partners, GV, Longwood Fund, Polaris Partners, Bruker Corporation, FUJIFILM Corporation, Alexandria Venture Investments and others.

Avalon Announces Better Way for Health Insurance Plans to Manage Growth and Costs of Genetic Testing

Avalon Announces Better Way for Health Insurance Plans to Manage Growth and Costs of Genetic Testing

AVIA Adds Five New Members to its Network of Leading Health Systems

Hyfe Unveils Next-Generation CoughPro App: Advanced Tracking and Community Features Revolutionize Chronic Cough Management

AI company transitions app to subscription model and adds exclusive new features for users in the UK, Canada, Europe and global users outside the U.S.

The ACSR Democratizes Access To Pathology Data With Proscia, Advancing Breakthroughs For HIV Cancer Patients

Distributing real-world data to researchers in hours instead of days

ENPICOM and Carterra Advance Antibody Screening by Integrating Biophysical Characterization and Repertoire Sequencing Analysis

Carterra Inc. and ENPICOM B.V. announced today a collaboration to streamline the analysis of rapidly growing sequencing and antibody screening data generated in the lab.

BugBiome wins Discovery Spark life science programme

BugBiome announced as the winner of the Discovery Spark life science business support programme and will be awarded a business support package worth over £100,000, including one year of free lab space at Discovery Park and £50,000 investment from Discovery Park Ventures.

VLPlant™ Is Set to Revolutionize Viral Vaccine Development